Current assessment and management of glomus tumors

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 5, 2008, Pages 420-426

  Semaan, Maroun T ^a   Megerian, Cliff A ^b,c  

^a HOUSE EAR INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Familial paraganglioma; Gamma knife; Glomus jugulare; Glomus tympanicum

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; GAMMA KNIFE RADIOSURGERY; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SCREENING; GLOMUS JUGULARE; GLOMUS TUMOR; GLOMUS TYMPANICUM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANGIOGRAPHY; CANCER STAGING; CHEMODECTOMA; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK TUMOR; IMAGE QUALITY; INCIDENCE; MALE; METHODOLOGY; PROGNOSIS; RADIOSURGERY; RISK ASSESSMENT; SURVIVAL RATE;

ANGIOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; GLOMUS JUGULARE TUMOR; GLOMUS TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PARAGANGLIOMA; PROGNOSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOSURGERY; RISK ASSESSMENT; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149345929     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32830c4595     Document Type: Review

References (46)

1. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002; 39:617-622.
2. Petropoulos AE, Luetje CM, Camarata PJ, et al. Genetic analysis in the diagnosis of familial paragangliomas. Laryngoscope 2000; 110:1225-1229.
3. Martin TP. What we call them: the nomenclature of head and neck paragangliomas. Clin Otolaryngol 2006; 31:185-186.
4. Grufferman S, Gillman MW, Pasternak LR, et al. Familial carotid body tumors: case report and epidemiologic review. Cancer 1980; 46:2116-2122.
5. van der Mey AG, Jansen JC, van Baalen JM. Management of carotid body tumors. Otolaryngol Clin North Am 2001; 34:907-924; vi.
6. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990; 102:382-390.
7. Shamblin WR, ReMine WH, Sheps SG, et al. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 1971; 122:732-739.
8. Sniezek JC, Netterville JL, Sabri AN. Vagal paragangliomas. Otolaryngol Clin North Am 2001; 34:925-939; vi.
9. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 1998; 20:374-378.
10. Farr HW. Carotid body tumors. A thirty year experience at Memorial Hospital. Am J Surg 1967; 114:614-619.
11. Mulligan LM, Marsh DJ, Robinson BG, et al. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 1995; 238:343-346.
12. Walther MM, Herring J, Enquist E, et al. von Recklinghausen's disease and pheochromocytomas. J Urol 1999; 162:1582-1586.
13. Chen F, KishidaT, Yao M, et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995; 5:66-75.
14. Zbar B, KishidaT, Chen F, et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996; 8:348-357.
15. Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002; 39:178-183.
16. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000; 26:268-270.
17. Heutink P, van der Mey AG, Sandkuijl LA, et al. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992; 1:7-10.
18. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287:848-851.
19. Baysal BE, van Schothorst EM, Farr JE, et al. Repositioning the hereditary paraganglioma critical region on chromosome band 11q23. Hum Genet 1999; 104:219-225.
20. Baysal BE, Rubinstein WS, Taschner PE. Phenotypic dichotomy in mitochondrial complex II genetic disorders. J Mol Med 2001; 79:495-503.
21. Niemann S, Steinberger D, Muller U. PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma. Neurogenetics 1999; 2:167-170.
22. Baysal BE. Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet C Semin Med Genet 2004; 129:85-90.
23. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytomaand to familial paraganglioma. Am J Hum Genet 2001; 69:49-54.
24. FuentesC, Menendez E, Pineda J, et al. The malignant potential of a succinate dehydrogenase subunit B germline mutation. J Endocrinol Invest 2006; 29:350-352.
25. Boedeker CC, Neumann HP, Maier W, et al. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 2007; 137:126-129.
26. Drovdlic CM, Myers EN, Peters JA, et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001; 111:1822-1827.
27. Eisenhofer G, Lenders JW, Linehan WM, et al. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999; 340:1872-1879.
28. van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005; 15:1310-1318.
29. van den Berg R, Schepers A, de Bruine FT, et al. The value of MR angiography techniques in the detection of head and neck paragangliomas. Eur J Radiol 2004; 52:240-245.
30. Nilssen E, Wormald PJ.The roleof MIBG scintigraphy in the management of a case of metastatic glomus jugulare tumour. J Laryngol Otol 1996; 110:373-375.
31. Reuland P,OverkampD,AicherKP,et al. Catecholamine secreting glomustumor detected by iodine-1 23-MIBG scintigraphy. J Nucl Med 1996; 37:463-465.
32. Eschun GM, Ludwig SM, Leslie W. Localization of a presumed catecholamine-secreting glomus tumor by 123I-metaiodobenzyl guanidine (MIBG) single photon emission computed tomography (SPECT) scanning. Am J Hypertens 1998; 11:258-262.
33. Muros MA, Llamas-Elvira JM, Rodriguez A, et al. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma. Nucl Med Commun 1998; 19:735-742.
34. Hoegerle S, Ghanem N, Altehoefer C, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003; 30:689-694.
35. Widimsky J Jr. Recent advances in the diagnosis and treatment of pheochromocytoma. Kidney Blood Press Res 2006; 29:321-326.
36. Tikkakoski T, Luotonen J, Leinonen S, et al. Preoperative embolization in the management of neck paragangliomas. Laryngoscope 1997; 107:821-826.
37. Fisch U. Infratemporal fossa approach for glomus tumors of the temporal bone. Ann Otol Rhinol Laryngol 1982; 91:474-479.
38. Pensak ML, Jackler RK. Removal of jugular foramen tumors: the fallopian bridge technique. Otolaryngol Head Neck Surg 1997; 117:586-591.
39. Oghalai JS, Leung MK, Jackler RK, et al. Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension. Otol Neurotol 2004; 25:570-579; discussion 579.
40. Sanna M, Jain Y, De Donato G, et al. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol 2004; 25:797-804.
41. Skolyszewski J, Korzeniowski S, Pszon J. Results of radiotherapy in chemodectoma of the temporal bone. Acta Oncol 1991; 30:847-849.
42. Willen SN, Einstein DB, Maciunas RJ, et al. Treatment of glomus jugulare tumors in patients with advanced age: planned limited surgical resection followed by staged gamma knife radiosurgery: a preliminary report. Otol Neurotol 2005; 26:1229-1234.
43. Cosetti M, Linstrom C, Alexiades G, et al. Glomus tumors in patients of advanced age: a conservative approach. Laryngoscope 2008; 118:270-274.
44. Varma A, Nathoo N, Neyman G, et al. Gamma knife radiosurgery for glomus jugulare tumors: volumetric analysis in 17 patients. Neurosurgery 2006; 59:1030-1036; discussion 1036.
45. Gerosa M, Visca A, Rizzo P, et al. Glomus jugulare tumors: the option of gamma knife radiosurgery. Neurosurgery 2006; 59:561-569; discussion 561-569.
46. Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004; 17:E4.